Immutep Company Top Insiders
| PRRUF Stock | USD 0.20 0.00 0.00% |
Immutep employs about 17 people. The company is managed by 6 executives with a total tenure of roughly 8 years, averaging almost 1.0 years of service per executive, having 2.83 employees per reported executive. Examination of Immutep's management performance can provide insight into the company performance.
| Marc Voigt CEO CEO, CFO, Chief Bus. Officer, Executive Director, Member of Audit and Risk Committee and Member of Remuneration Committee |
Immutep |
Immutep Management Team Effectiveness
The company has return on total asset (ROA) of (0.2296) % which means that it has lost $0.2296 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.3849) %, meaning that it generated substantial loss on money invested by shareholders. Immutep's management efficiency ratios could be used to measure how well Immutep manages its routine affairs as well as how well it operates its assets and liabilities.Immutep Workforce Comparison
Immutep Limited is considered to be number one stock in number of employees category among its peers. The total workforce of Biotechnology industry is at this time estimated at about 2,862. Immutep maintains roughly 17.0 in number of employees contributing less than 1% to stocks in Biotechnology industry.
Immutep Limited Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Immutep Limited Price Series Summation is a cross summation of Immutep price series and its benchmark/peer.
Immutep Notable Stakeholders
An Immutep stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Immutep often face trade-offs trying to please all of them. Immutep's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Immutep's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Marc Voigt | CEO, CFO, Chief Bus. Officer, Executive Director, Member of Audit and Risk Committee and Member of Remuneration Committee | Profile | |
| Frederic MD | Chief Officer | Profile | |
| Deanne LLB | Gen COO | Profile | |
| Indira Naidu | Joint Sec | Profile | |
| Shengfei Fang | F Sec | Profile | |
| Christian Mueller | Director Affairs | Profile |
About Immutep Management Performance
The success or failure of an entity such as Immutep Limited often depends on how effective the management is. Immutep management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Immutep management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Immutep management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical products. Immutep Limited was incorporated in 1987 and is headquartered in Sydney, Australia. Immutep operates under Biotechnology classification in the United States and is traded on OTC Exchange.
Immutep Workforce Analysis
Traditionally, organizations such as Immutep use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Immutep within its industry.Immutep Manpower Efficiency
Return on Immutep Manpower
| Revenue Per Employee | 14.6K | |
| Revenue Per Executive | 41.3K | |
| Net Loss Per Employee | 1.9M | |
| Net Loss Per Executive | 5.4M | |
| Working Capital Per Employee | 1.2M | |
| Working Capital Per Executive | 3.5M |
Complementary Tools for Immutep Pink Sheet analysis
When running Immutep's price analysis, check to measure Immutep's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immutep is operating at the current time. Most of Immutep's value examination focuses on studying past and present price action to predict the probability of Immutep's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immutep's price. Additionally, you may evaluate how the addition of Immutep to your portfolios can decrease your overall portfolio volatility.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |